Related Experiment Videos
Bilateral endogenous necrotizing scleritis due to Aspergillus oryzae
Summary
A rare case of necrotizing scleritis caused by Aspergillus oryzae in a former intravenous drug user is presented. The patient successfully responded to combined antifungal therapies, marking a unique instance of isolated scleral involvement.
Area of Science:
- Ophthalmology
- Mycology
- Infectious Diseases
Background:
- Endogenous fungal infections can manifest in the eye, posing significant diagnostic and therapeutic challenges.
- Aspergillus species are known pathogens, but Aspergillus oryzae is rarely implicated in human disease, particularly ocular infections.
Observation:
- A former intravenous drug user presented with bilateral necrotizing scleritis.
- A remote seeding focus in the thoracic spine was identified as the source of infection.
- The patient had a prior history of meningitis caused by Aspergillus oryzae.
Findings:
- This case represents the first reported instance of ocular disease caused by Aspergillus oryzae.
- The patient experienced successful treatment with a combination of local and systemic antifungal agents, including amphotericin B, flucytosine, and natamycin.
- This is also the first reported case of isolated scleral, non-intraocular involvement in endogenous oculomycosis.
Implications:
- Highlights the potential for rare Aspergillus species to cause severe ocular disease.
- Demonstrates the efficacy of combined antifungal therapy in managing complex endogenous fungal scleritis.
- Emphasizes the importance of considering fungal infections in immunocompromised patients with unexplained ocular inflammation.